KX ADVISORS
LIVE

Serial Number

98564150

Owner

BGB Communications, LLC

Attorney

Lori P. Hager, Esq.

Filing Date

May 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

KX ADVISORS Trademark

Serial Number: 98564150 • Registration: 8224574

KX ADVISORS is a trademark filed by BGB Communications, LLC on May 22, 2024. The trademark is classified under Class 36 (Insurance & Financial), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

BGB Communications, LLC (23 trademarks)

38 Greene St., 4th Fl
New York, NY 10013

Entity Type: 16

Trademark Details

Filing Date

May 22, 2024

Registration Date

April 21, 2026

Published for Opposition

July 29, 2025

Goods & Services

Advertising agencies specializing in pharmaceutical branding, product launch and mature products, business consulting for all stages of a product; Advertising and marketing consultancy and strategies, namely, Advertising agencies specializing in marketing strategies to promote business; Advertising and marketing consultancy regarding access to the pharmaceutical market and pricing strategies for pharmaceutical products and brands; marketing and strategic marketing consulting for product development in the pharmaceutical industry; consultancy for marketing strategies using artificial intelligence; Advertising and publicity services, namely, promoting the goods, services, brand identity and commercial information and news of third parties through digital technology, video, and live events; Advertising consultation; Advertising services in the field of pharmaceuticals; Advertising services, namely, creating corporate and brand identity for others; Advertising services, namely, promoting and marketing the goods and services of others in the field of pharmaceuticals via print and electronic media; Advertising, marketing and promotion services in the field of pharmaceuticals; Brand concept and brand development services for corporate clients; Business consultation in the field of pharmaceuticals; Concept and brand development in the field of pharmaceuticals; Concept and brand development services for corporate clients; Conducting market surveys; Digital advertising services; Market analysis and research services; Marketing consultation in the field of pharmaceuticals; Marketing consulting; Marketing plan development; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; Providing advertising, marketing and promotional services for the pharmaceutical and medical products of others; all of the above related to pharmaceutical businesses and products goods and services and being in the field of the pharmaceuticals industry.

Advisory services relating to investments, strategic corporate financial advisory services; advisory services related to financial profiles; financial revenue forecasts

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 21, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 21, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 31, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 31, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 31, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 30, 2026 AITU
USE AMENDMENT FILED
Sep 30, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 30, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 23, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 29, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 29, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 23, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2025 CNSA
ASSIGNED TO EXAMINER
Jun 23, 2025 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 12, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 12, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 18, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 18, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 23, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 23, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 23, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 6, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 3, 2024 NWOS
NEW APPLICATION ENTERED
May 22, 2024 NWAP